Department of Respiratory medicine, Kasturba Medical College Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
BMC Pulm Med. 2024 Mar 15;24(1):132. doi: 10.1186/s12890-024-02951-9.
This is a letter in response to an article by Ahmed et al., which concluded that in comparison to salbutamol, Fluticasone/salmeterol combination increases FEV, FEV% of predicted, and FEV/FVC ratio, however it did not offer novel insights, as both agents met the 12%- and 200-mL reversibility benchmarks and Concerns about incorporating a combination medication that includes an inhaled corticosteroid, inhaled corticosteroids are not typically associated with bronchodilation.
这是一封针对 Ahmed 等人文章的回复信，该文章得出结论，与沙丁胺醇相比，氟替卡松/沙美特罗联合用药可增加 FEV、预计 FEV%和 FEV/FVC 比值，但并未提供新的见解，因为两种药物均符合 12%和 200 毫升的可逆性标准，并且人们担心使用包含吸入性皮质类固醇的联合药物，因为吸入性皮质类固醇通常与支气管扩张无关。
